Activated miR-203a could suppress the hepatocellular carcinoma cells progression and induce the cell apoptosis by targeting HOXD3 through EGFR/AKT and ERK signaling pathway (Figure 6). This evidence concerns the gene AKT1 and hepatocellular carcinoma.